Breaks Categories: News

WednesdayJun 27, 2018 9:24 am

HempNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) to File IND, CTA with Health Authorities to Conduct Human Trials of PVT-005 in US and Canada

Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it will file an Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) and Clinical Trial Application (“CTA”) with Health Canada to begin human clinical trials of its pharmaceutical drug candidate for the treatment of Female Hypoactive Sexual Desire Disorder (“HSDD”), PVT-005. Pivot will employ its drug formulation and delivery platform technologies to develop a topical cream containing cannabinoids for perimenopausal, menopausal and post-menopausal women who have observed a decline in sexual desire and response. "In vitro results from our contract research laboratory indicated…

Continue Reading

TuesdayJun 26, 2018 1:54 pm

HempNewsBreaks – Marijuana Company of America Inc. (MCOA) Prepared to Cultivate Opportunity in Okanogan County, Washington

Marijuana Company of America Inc. (OTC: MCOA) has completed phase one construction of its Okanogan County, Washington greenhouse facilities in time for the 2018 planting season. An article discussing the venture reads: “The joint venture will lease the turnkey property to a third-party licensed tenant, thus acting solely as a landlord. The tenant will be able to take occupation of the property and begin cultivation once the inspection is approved. As a turnkey landlord, BV-MCOA aims to provide an ideal cultivation environment for its future tenants. The company anticipates completion of greenhouse facilities for its entire 30,000 square foot cultivation…

Continue Reading

TuesdayJun 26, 2018 11:18 am

HempNewsBreaks – EVIO, Inc.’s (EVIO) Berkeley, CA Lab Receives ISO 17025 Accreditation

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, this morning announced that its laboratory located in Berkeley, California, C3 Labs, LLC DBA EVIO Labs, has attained ISO 17025 accreditation from Perry Johnson Laboratory Accreditation, Inc. (“PJLA”). ISO 17025 accreditation is the highest recognized quality standard for calibration and testing laboratories, requiring personnel to have met specific academic and training credentials. The accreditation also requires the facility to operate under a quality management system and consistently produce precise and accurate tests for cannabinoids, pesticides, and contaminants. "EVIO is committed to upholding…

Continue Reading

TuesdayJun 26, 2018 10:58 am

HempNewsBreaks – Medical Cannabis Payment Solutions (REFG) Details Plans to Pursue Hemp Cultivation Program in Vermont

Cannabis-focused financial services company Medical Cannabis Payment Solutions (OTC: REFG) this morning announced that it is working on growing industrial hemp as part of Vermont’s industrial hemp program. Per the update, the company is currently evaluating multiple properties to commence growing and anticipates completing its first harvest in 2019. “While we are fully committed to our solution to the banking and financial transaction problems in the state sanctioned marijuana industry, we are pleased thus far with our diversification into CBD extraction,” Jeremy Roberts, CEO of REFG, stated in the news release. “With the recent approval of a CBD based medicine…

Continue Reading

TuesdayJun 26, 2018 10:40 am

HempNewsBreaks – SinglePoint, Inc. (SING) to Present at the National Investment Banking Conference; Provides Company Update

SinglePoint, Inc. (OTCQB: SING) this morning announced that it will be presenting at the National Investment Banking Association Conference (“NIBA”) in New York. NIBA provides the company the opportunity to attract additional institutional coverage due to the improvements in the corporate structure. During the two-day conference, company management will be presenting and meeting with investors to increase visibility and build momentum for SinglePoint. The company believes that many milestones it has reached in the past six months, including its completed audits, up-listing to the OTCQB and Form 10 filing to become a fully reporting company, will help attract opportunities for…

Continue Reading

TuesdayJun 26, 2018 10:00 am

HempNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Appoints New Director of Operations

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced its appointment of Kyp Rowe as its new director of operations. Per the update, Rowe will play a key role in Choom’s strategic development moving forward, leading the company’s premium craft cannabis cultivation strategy in support of its retail roll-out for the Canadian recreational market. “Bringing Kyp onboard significantly strengthens our team as we continue to prepare for when the Canadian recreational cannabis market commences on October 17, 2018,” Chris Bogart, president and CEO of Choom, stated in the news release. “Kyp brings over 20…

Continue Reading

MondayJun 25, 2018 9:28 am

HempNewsBreaks – EVIO, Inc. (EVIO) Announces Retirement of Convertible Debt in Conjunction with North American Expansion Efforts

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, this morning announced that floorless convertible notes issued pursuant to its 2017 debt offerings, which were raised to facilitate key acquisitions and expansions, have been fully retired. Per the update, the company has no further obligations under the notes of those offerings. “We're pleased to have these convertible debentures fully retired as we continue to strengthen EVIO's balance sheet and focus on improving shareholder value,” William Waldrop, CEO of EVIO, stated in the news release. “As communicated with our shareholders last fall,…

Continue Reading

FridayJun 22, 2018 9:52 am

HempNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Details Plans for Additional Cannabis Production Facility

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced its decision to add a 287,245 sq. ft. purpose-built facility on its Valleyfield property capable of producing 40,000 kg of premium organic cannabis. Per the update, this new facility will be dedicated to the company’s beverage division, and it will increase TGOD’s fully-funded capacity to 170,000 kg. TGOD intends to use excess cash raised in its IPO and subsequent bought deal financings to fund the construction of this new facility. “With the legalization of cannabis announced on June 20th, and Premier Justin…

Continue Reading

FridayJun 22, 2018 9:38 am

HempNewsBreaks – SinglePoint, Inc. (SING) President Discusses Form 10 Filing in Interview on MoneyTV

SinglePoint, Inc. (OTCQB: SING) was a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program discussing “money and what makes it happen.” In this week’s episode, SinglePoint President Wil Ralston discussed the company’s recently filed Form 10. “We've got a great team here and everybody really put their all into this. We're all very happy that we got it filed,” SinglePoint President Wil Ralston stated in the interview. “It really opens up for family offices, institutions and those larger players to help get in and get a position and actually start…

Continue Reading

ThursdayJun 21, 2018 1:47 pm

HempNewsBreaks – Aphria Inc. (TSX: APH) (OTC: APHQF) Subsidiary Obtains First Cannabis Import License Issued by the Malta Medicines Authority

Aphria Inc. (TSX: APH) (OTC: APHQF) recently announced that its Malta-based subsidiary, ASG Pharma ("ASG"), has received the first import license for medical cannabis issued by the Malta Medicines Authority. The license enables ASG, a high-capacity EU GMP-certified lab, to import medical cannabis for analytical testing and research. The receipt of the license marks a significant milestone for the company, positioning ASG at the forefront of testing, research and development of medical cannabis in Europe. "Our EU GMP-certified lab in Malta will not only be a leading European center for R&D and testing, but also will provide a gateway to…

Continue Reading